Citation
Noorjahan Banu Mohammed Alitheen.
(2010)
Newcastle disease virus activated human peripheral blood mononuclear cells and their use in cancer therapy.
PI2010700088.
Abstract
This invention provides a method for immune activation of human peripheral blood mononuclear cells (PBMC) by treatment with immunogens derived from New Castle Disease virus (NDV). The invention describes a method of activation of PBMC by NDV, the activated PBMCs produced by the inventive method as well as pharmaceutical compositions and vaccines comprising the same. Further embodiments of the invention relate to the use of NDV derived immunogens and the inventive activated PBMCs in immunetheraphy of proliferative diseases - such as cancer. The invention finally provides a method for killing target cells, preferably cancer cells, by co-culturing the target cells together with the inventive activated PBMCs.
Download File
Full text not available from this repository.
|
Additional Metadata
| Item Type: | Patent |
|---|---|
| Application Number: | PI2010700088 |
| Filing Date: | 2010-11-30 |
| Divisions: | Faculty of Biotechnology and Biomolecular Sciences |
| Keywords: | Newcastle disease; Peripheral blood mononuclear cell; Virus; Cancer. |
| Depositing User: | Nurul Ainie Mokhtar |
| Date Deposited: | 03 Sep 2014 06:30 |
| Last Modified: | 03 Sep 2014 06:30 |
| URI: | http://psasir.upm.edu.my/id/eprint/32058 |
| Statistic Details: | View Download Statistic |
Actions (login required)
 |
View Item |